Zhejiang Wecome Pharmaceutical Company Limited

¥31.30As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300878Healthcare
Country China
PE (Fwd) •••
TSR 6Y CAGR (2.77%)
Div yield —
ROE (13.34%)
Biotechnology
Beta (5Y) 0.65
PE TTM —
TSR TTM 25.65%
Mkt cap ¥4.446B
ROIC (6.21%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥36
15.49%
(85.21%)
Hold 6|11|6|1|2
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.52
0.57
0.61
0.59
24.95%
34.46%
39.21%
25.76%
Revenue¥M
244.5
254.4
247.6
260.7
8.62%
11.81%
5.89%
5.37%
Peers (US$666.5M)
Cap (US$)
PE
681.7M
26.80x
662.9M
18.20x
Capital
TTM
5Y
10Y
Leveragex
1.320
(0.011)
—
EBIT/Intx
0.700
0.103
0.100
Own earn%
(27.45)
(83.48)
(95.86)
Sh yield%
47.14
37.04
38.87
Owners
Insiders/Inst%
4.34
70.92
Short interest%
0.83
SBC / revenue%
0.90
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
12–14
$1 testx
—
Incr. ROIC%
29